PRICE T ROWE ASSOCIATES INC 13D and 13G filings for Ultragenyx Pharmaceutical Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:03 am Sale |
2023-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 3,453,460 4.200% |
-642,928 (-15.69%) |
Filing |
| 2023-02-14 12:38 pm Sale |
2022-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 4,096,388 5.800% |
-1,579,610 (-27.83%) |
Filing |
| 2022-08-10 2:56 pm Sale |
2022-07-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 5,675,998 8.100% |
-5,849,091 (-50.75%) |
Filing |
| 2022-02-14 2:34 pm Purchase |
2021-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 11,525,089 16.900% |
2,054,597 (+21.69%) |
Filing |
| 2021-02-16 12:23 pm Purchase |
2020-12-31 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 9,470,492 14.300% |
2,851,572 (+43.08%) |
Filing |
| 2020-05-11 1:21 pm Purchase |
2020-04-30 | 13G | Ultragenyx Pharmaceutical Inc. RARE |
PRICE T ROWE ASSOCIATES INC | 6,618,920 11.100% |
2,127,151 (+47.36%) |
Filing |